Recruitment And Diversity

51. Improving Clinical Trials Accessibility For Patients With Disabilities 11/29/2023

    While increasing DE&I in clinical trials is essential to all individuals, this article speaks to considerations for removing barriers and improving trial accessibility for individuals with disabilities. Discussion includes combating stigma and bias, changing structural design, and more.

52. Addressing Barriers To Adolescent And Young Adult Participation In Cancer Trials 11/27/2023

    While the challenges of cancer diagnosis, treatment, and survivorship are well-known, adolescents and young adults (AYAs), ages 15-39, have specific hurdles. Challenges in clinical care that occur in this age group also are mirrored in research, where a deficit of AYAs are represented.

53. How Pfizer Prioritizes Diversity When Implementing Multiple Myeloma Trials 11/21/2023

    Every patient deserves the chance to feel seen, heard, and prioritized in research and care — and for Black individuals with multiple myeloma, it’s a matter of urgency. 

54. 3 Steps To Improve & Measure Your Clinical Trial Patient Diversity Efforts 11/21/2023

    Even with the increase in investment to improve clinical trial diversity, many clinical teams are unclear on how to develop an optimal set of metrics to measure the success of diversity initiatives. Here are three steps to support your efforts.

55. Medical Director, PI, And Educator: A 3D Perspective On Diverse Patient Enrollment 11/13/2023

    Based on experiences as a medical director, an IRB board member and PI, and an academician, Monique Gary, DO, MSc, FACS, FSSO, discusses diverse patient enrollment as well as ways in which sponsors, sites, advocates, and others can better serve minority and LGBTQ+ trial participants.

56. Putting Patients First: Human-Centric Approaches In Digital Healthcare 11/8/2023

    Human-centric design should be the starting point for identifying the core issues that drive innovation, experimentation, and finding solutions to unlock the full potential of digital health. Amy West, head of U.S. digital transformation & innovation at Novo Nordisk, explains.

57. 3 Reasons People Don't Enroll In Clinical Trials — And How To Overcome Them 10/30/2023

    Adrelia Allen, executive director, clinical trial patient diversity, at Merck, outlines three reasons people don't participate in clinical trials and offers ways to overcome them.

58. As Protocol Complexity Grows, AI Decreases Site Workload And Improves Patient Recruitment 10/23/2023

    Cedar Health Research CEO Todd Albin discusses ways in which AI-assisted technologies can improve upon traditional patient recruitment and enrollment strategies.

59. Choosing Community-Based Centers To Boost Trial Diversity, Expand Patient Access 10/17/2023

    In this Q&A, Jeffrey Jones, MD, MPH, MBA, chief medical officer at Cullinan Oncology, discusses conducting trials in community-based centers to extend participation to underserved populations.

60. How Cultural Competency Can Increase Clinical Trial Diversity 10/13/2023

    Clinical trial technology helps researchers reach more patients, but it alone can't address the lack of participant diversity. So how do we get underserved patients to feel safe, have trust, and enroll in a clinical trial? With cultural competency.